EP0147716A3
(en)
|
1983-12-24 |
1987-10-28 |
ANT Nachrichtentechnik GmbH |
Method and apparatus for the encipherable transmission of a series of binary information signals with authenticity check
|
JPS6235216A
(en)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
Method and device for measuring thickness of heterogeneous material layer nondestructively
|
US4873253A
(en)
*
|
1987-03-30 |
1989-10-10 |
Shosuke Okamoto |
Phenylalanine derivative and proteinase inhibitor
|
US5187157A
(en)
|
1987-06-05 |
1993-02-16 |
Du Pont Merck Pharmaceutical Company |
Peptide boronic acid inhibitors of trypsin-like proteases
|
GR1001529B
(en)
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Process for the obtainment of a new pregna-1,4-diene-3,20-dione -16-17-acetal-21 esters
|
GB9019558D0
(en)
|
1990-09-07 |
1990-10-24 |
Szelke Michael |
Enzyme inhibitors
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
SE9301911D0
(en)
|
1993-06-03 |
1993-06-03 |
Ab Astra |
NEW PEPTIDE DERIVATIVES
|
US5464820A
(en)
|
1993-06-22 |
1995-11-07 |
The University Hospital |
Specific inhibitors of tissue kallikrein
|
GB9318637D0
(en)
|
1993-09-08 |
1993-10-27 |
Ferring Res Ltd |
Enzyme inhibitors
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
HUP0300832A2
(en)
|
2000-04-27 |
2003-08-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel, slow-acting betamimetics, a method for their production and their use as medicaments and pharmaceutical compositions containing them
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
WO2002070490A1
(en)
|
2001-03-08 |
2002-09-12 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
DE60224172T2
(en)
|
2001-03-22 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
FORMANILID DERIVATIVES AS BETA2 ADRENOR RECEPTOR AGONISTS
|
DK1425001T3
(en)
|
2001-09-14 |
2009-04-14 |
Glaxo Group Ltd |
Phenethanolamine derivatives for the treatment of respiratory diseases
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
EP1458682B1
(en)
|
2001-12-20 |
2006-08-30 |
Bayer HealthCare AG |
1,4-dihydro-1,4-diphenylpyridine derivatives
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2005523920A
(en)
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
Phenetanolamine derivative
|
EP1507754A1
(en)
|
2002-05-28 |
2005-02-23 |
Theravance, Inc. |
Alkoxy aryl beta-2 adrenergic receptor agonists
|
WO2003101941A2
(en)
|
2002-05-31 |
2003-12-11 |
Genzyme Corporation |
Alpha acyloxyacetamides for kallikrein and urokinase inhibition
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR040962A1
(en)
|
2002-08-09 |
2005-04-27 |
Novartis Ag |
COMPOUNDS DERIVED FROM TIAZOL 1,3-2-ONA, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS
|
ES2293077T3
(en)
|
2002-08-27 |
2008-03-16 |
Bayer Healthcare Ag |
DERIVATIVES OF DIHYDROPIRIDINONE AS HNE INHABITORS.
|
GB0219896D0
(en)
|
2002-08-27 |
2002-10-02 |
Bayer Ag |
Dihydropyridine derivatives
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1546113B1
(en)
|
2002-09-10 |
2013-05-01 |
Bayer Intellectual Property GmbH |
Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
|
WO2004024701A1
(en)
|
2002-09-10 |
2004-03-25 |
Bayer Healthcare Ag |
Heterocyclic derivatives
|
DE10246374A1
(en)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
CA2499314C
(en)
|
2002-10-11 |
2010-08-24 |
Pfizer Inc. |
Indole derivatives as beta-2 agonists
|
ES2291733T3
(en)
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
MEDICAL ARYLETHANOLAMINE COMPOUNDS.
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR041724A1
(en)
|
2002-10-28 |
2005-05-26 |
Glaxo Group Ltd |
COMPOUNDS DERIVED FROM PHENETANOLAMINE AND ITS USE IN PHARMACEUTICAL COMPOSITIONS
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2004161702A
(en)
|
2002-11-14 |
2004-06-10 |
Hokko Chem Ind Co Ltd |
METHOD FOR PRODUCING gamma-JASMOLACTONE
|
DE10253282A1
(en)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
|
DE10253220A1
(en)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New 2-(N-phenylalkyl-amino)-1-phenyl-ethanol derivatives, are beta-adrenergic agents especially useful for treating inflammatory and obstructive respiratory diseases such as asthma or COPD
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
DE10258695A1
(en)
|
2002-12-16 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New 2-(2-hydroxy-2-(3-methylsulfonylamino-4-hydroxyphenyl)ethylamino-4-(pyrid-2-ylamino)-2-methylbutane used e.g. for treating asthma and chronic obstructive pulmonary disease
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
WO2004089892A2
(en)
|
2003-04-01 |
2004-10-21 |
Theravance, Inc. |
Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
|
ATE421322T1
(en)
|
2003-04-04 |
2009-02-15 |
Novartis Pharma Gmbh |
QUINOLIN-2-ONE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
JP4616264B2
(en)
|
2003-05-28 |
2011-01-19 |
セラヴァンス, インコーポレーテッド |
Azabicycloalkane compounds as muscarinic receptor antagonists
|
ES2298757T3
(en)
|
2003-06-04 |
2008-05-16 |
Pfizer Inc. |
DERIVATIVES OF Z-AMINO-PIRIDINA AS BETA-2 ADRECORRECEPTORS AGONISTS.
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
SE0302324D0
(en)
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302323D0
(en)
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302487D0
(en)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
SE0302486D0
(en)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
WO2005033121A2
(en)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
|
GB0323701D0
(en)
|
2003-10-09 |
2003-11-12 |
Glaxo Group Ltd |
Formulations
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
CN100450488C
(en)
|
2003-11-03 |
2009-01-14 |
诺顿·希尔思凯尔有限公司 |
Soft steroid compositions for use in dry powder inhalers
|
GB0328490D0
(en)
|
2003-12-09 |
2004-01-14 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US20050167331A1
(en)
|
2003-12-19 |
2005-08-04 |
Bhan Opinder K. |
Systems, methods, and catalysts for producing a crude product
|
DE102004001413A1
(en)
|
2004-01-09 |
2005-08-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of chronic obstructive pulmonary disease
|
TW200531692A
(en)
|
2004-01-12 |
2005-10-01 |
Theravance Inc |
Aryl aniline derivatives as β2 adrenergic receptor agonists
|
RS50561B
(en)
|
2004-01-22 |
2010-05-07 |
Pfizer Inc. |
Sulfonamide derivatives for the treatment of diseases
|
DK1708992T3
(en)
|
2004-01-22 |
2007-11-05 |
Pfizer |
Sulfonamide derivatives for the treatment of diseases
|
DE102004003428A1
(en)
|
2004-01-23 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New long-acting beta-2 agonists, and their use as pharmaceuticals
|
EP1720546B1
(en)
|
2004-02-14 |
2010-09-01 |
Boehringer Ingelheim International GmbH |
Novel, sustained-action beta-2-agonists and their use as medicaments
|
ATE516285T1
(en)
|
2004-02-19 |
2011-07-15 |
Bayer Schering Pharma Ag |
DIHYDROPYRIDINONE DERIVATIVES
|
ES2394177T3
(en)
|
2004-02-26 |
2013-01-23 |
Bayer Intellectual Property Gmbh |
1,4-diaryl-dihydropyrimidin-2-one and its use as inhibitors of human neutrophil elastase
|
ES2428503T3
(en)
|
2004-02-26 |
2013-11-08 |
Bayer Intellectual Property Gmbh |
1,4-Diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
|
WO2005092861A1
(en)
|
2004-03-11 |
2005-10-06 |
Pfizer Limited |
Quinolinone derivatives pharmaceutical compositions containing them and their use
|
EP1577292A1
(en)
|
2004-03-17 |
2005-09-21 |
Pfizer Limited |
Phenylaminoethanol derivatives as beta2 receptor agonists
|
EP1577306A1
(en)
|
2004-03-17 |
2005-09-21 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
|
HN2004000023A
(en)
|
2004-03-22 |
2007-11-23 |
Mars Inc |
ANIMAL MASCADURE
|
BRPI0507877A
(en)
|
2004-03-23 |
2007-07-24 |
Pfizer |
formamide derivatives, pharmaceutical composition, use thereof and combination
|
ATE432278T1
(en)
|
2004-03-23 |
2009-06-15 |
Pfizer |
COMPOUNDS FOR TREATING DISEASES
|
WO2005092860A1
(en)
|
2004-03-23 |
2005-10-06 |
Pfizer Limited |
Compounds for the treatment of diseases
|
WO2005092841A1
(en)
|
2004-03-23 |
2005-10-06 |
Pfizer Limited |
Compounds having beta-agonist activity
|
EP1736465A4
(en)
|
2004-03-31 |
2009-06-17 |
Ajinomoto Kk |
Aniline derivatives
|
EP1595873A1
(en)
|
2004-05-13 |
2005-11-16 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Substituted cycloalkyl derivatives for the treatment of respiratory diseases
|
EP1789394A1
(en)
|
2004-05-13 |
2007-05-30 |
Boehringer Ingelheim International Gmbh |
Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
|
DE102004024454A1
(en)
|
2004-05-14 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
|
DE102004024451A1
(en)
|
2004-05-14 |
2005-12-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder formulations for inhalation containing enantiomerically pure beta agonists
|
US7402673B2
(en)
|
2004-06-03 |
2008-07-22 |
Theravance, Inc. |
Diamine β2 adrenergic receptor agonists
|
EP1778638A1
(en)
|
2004-07-21 |
2007-05-02 |
Theravance, Inc. |
Diaryl ether beta2 adrenergic receptor agonists
|
EP1807451A2
(en)
|
2004-08-03 |
2007-07-18 |
Dyax Corporation |
Hk1-binding proteins
|
WO2006016245A1
(en)
|
2004-08-05 |
2006-02-16 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
JP2008512470A
(en)
|
2004-09-10 |
2008-04-24 |
セラヴァンス, インコーポレーテッド |
Amidine-substituted arylaniline compounds
|
DE102004045648A1
(en)
|
2004-09-21 |
2006-03-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New betamimetics for the treatment of respiratory diseases
|
WO2006051373A1
(en)
|
2004-11-12 |
2006-05-18 |
Pfizer Limited |
Compounds for the treatment of diseases
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
AU2007281220B2
(en)
|
2006-07-31 |
2013-08-15 |
Activesite Pharmaceuticals, Inc. |
Inhibitors of plasma kallikrein
|
GB0807828D0
(en)
*
|
2008-04-29 |
2008-06-04 |
Vantia Ltd |
Aminopyridine derivatives
|